Canine CRP at ADLM 2024

Learn more about Gentian's turbidimetric canine CRP at booth #3201

Gentian Diagnostics will also this year be present at ADLM to promote our automated canine CRP immunoassay. The assay can be applied to a wide range of clinical chemistry analysers, offering high inter-instrument accuracy for serum and plasma samples.

Canine CRP assay continuously available since 2013

The Gentian Canine CRP Immunoassay is an open channel turbidimetric assay for quantitative determination of canine CRP in dog plasma and serum on clinical chemistry instruments already present in the lab. The assay has been developed by utilising canine-specific antibodies from avian origin which minimises batch variation and interference with mammalian factors.

The open channel assay can be applied on a wide range of automated clinical chemistry analysers.

Why Gentian Canine CRP Immunoassay?

• Canine-specific antibodies ensure consistent specificity to the canine CRP antigen
• Avian origin of antibodies contributes to reduced interference
• Instrument-independent and validated on a wide range of clinical analysers

Inflammation in dogs - early and rapid detection with CRP

C-reactive protein (CRP) is an inflammation marker in canine serum and plasma, important in diagnosis of infections and inflammatory conditions such as gastrointestinal diseases, surgical trauma, autoimmune diseases and neoplasia¹. As a major acute phase protein, CRP levels can quickly rise to more than 100 times its original concentration, with significant changes detectable after just 4-6 h^2,3. Due to its short half-life, CRP can also be analysed to monitor disease development and treatment efficacy⁴.

Early detection of canine CRP allows for precise diagnosis and quick individualised patient decisions, enabling reduced care time and improved patient outcomes.

Contact us for more information and ordering

References:

1. Ceron et al. Vet Clin Pathol. 2005; 34:85-993
2. Pepys et al. J Clin Invest. 2003; 111(12): 1805–1812
3. Eckershall et al. Vet J. 2010; 185:23-27
4. Vigushin et al. J. Clin. Invest. 1993; 91:1351–1357

This website may contain information about products that are not registered for use in your country of residence and may not comply with applicable laws or regulations in that country. We do not take any responsibility for accessing such information in those circumstances.